Clinical Trials in San Francisco

Showing 12521-12540 of 12,991 trials

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

NCT00259727

The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.

DiabetesHIV InfectionsInsulin Resistance

US Department of Veterans Affairs80 participantsStarted Jan 2006

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

NCT00829777

The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects

Opiate Addiction

California Pacific Medical Center Research Institute8 participantsStarted Mar 2009

San Francisco, California, United States

UNKNOWNPhase 4< 1 mile

Kronos Early Estrogen Prevention Study (KEEPS)

NCT00154180

The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition.

MenopauseArteriosclerosis

Kronos Longevity Research Institute728 participantsStarted Sep 2005

Phoenix, Arizona, United States • San Francisco, California, United States • New Haven, Connecticut, United States +6 more locations

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

Kronos Early Estrogen Prevention Study (KEEPS)

Find Trials by Condition in San Francisco

Application of the Apsara Thermal Wand System

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Educational Intervention on Weight Management in Chinese-American Children

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Duloxetine Versus Placebo for Osteoarthritis Knee Pain

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients